Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 28, 2024

VHL Suppresses Autophagy and Tumor Growth Through PHD1-Dependent Beclin1 Hydroxylation

The EMBO Journal


Additional Info

The EMBO Journal
VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation
EMBO J 2024 Mar 01;43(6)931-955, Z Wang, M Yan, L Ye, Q Zhou, Y Duan, H Jiang, L Wang, Y Ouyang, H Zhang, Y Shen, G Ji, X Chen, Q Tian, L Xiao, Q Wu, Y Meng, G Liu, L Ma, B Lei, Z Lu, D Xu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading